| Breast Cancer |
1 |
1 |
| Menopause |
0 |
0.85 |
| Breast |
0 |
0.65 |
| Breast Cancer History |
0 |
0.57 |
| Estrogen |
0 |
0.55 |
| Selective Estrogen Receptor Modulators |
0 |
0.54 |
| Cancer |
0 |
0.38 |
| Breast Pain |
0 |
0.37 |
| Endometrial Cancer |
0 |
0.36 |
| Bone |
0 |
0.28 |
| Bone Density |
0 |
0.28 |
| Cancer Risk |
0 |
0.28 |
| Spine |
0 |
0.2 |
| Sexual Dysfunction in Female |
0 |
0.19 |
| Osteoporosis |
0 |
0.18 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Dyspareunia |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Uterus |
0 |
0.13 |
| Fractures |
0 |
0.12 |
| Tissue |
0 |
0.11 |
| Clinical Research |
0 |
0.1 |
| Spinal Fractures and Dislocations |
0 |
0.08 |
| Vagina |
0 |
0.08 |
| Gland |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Animal Research |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Hemorrhage |
0 |
0.04 |
| Hormonal Therapy |
0 |
0.04 |
| Meta-Analysis |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Abnormal Mammogram |
0 |
0.03 |
| Lumbar Spine |
0 |
0.03 |
| Cerebrovascular Accident |
0 |
0.02 |
| Dorsum |
0 |
0.02 |
| Infarction |
0 |
0.02 |
| Lipids Management |
0 |
0.02 |
| Mammogram |
0 |
0.02 |
| Minerals |
0 |
0.02 |
| Myocardial Infarction (MI) |
0 |
0.02 |
| Pain |
0 |
0.02 |
| Pain Management |
0 |
0.02 |
| Polyp |
0 |
0.02 |
| Quality of Life |
0 |
0.02 |
| Sleep |
0 |
0.02 |
| Vertebral Fracture |
0 |
0.02 |